Since triple-negative breast cancer (TNBC) was first defined over a decade ago, increasing
studies have focused on its genetic and molecular characteristics. Patients diagnosed with …

The objective of this review is to elucidate the role of miRNAs in triple negative breast cancer
(TNBC). To achieve our goal, we searched databases such as PubMed, ScienceDirect …

Breast cancer (BrCa) is the leading cause of cancer incidence and mortality in women
worldwide. While BrCa treatment has been shown to be highly successful if detected at an …

MicroRNAs (miRNAs) are small non-coding RNAs (18–24 nucleotides) that play significant
roles in cell proliferation, development, invasion, cancer development, cancer progression …

The programmed death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) is a well-
established inhibitory immune checkpoint axis in triple-negative breast cancer (TNBC) …

Although ongoing medical research is working to find a cure for a variety of cancers, it
continues to be one of the major causes of death worldwide. Chemotherapy and …

Abstract Trisomy 21 (T21) causes Down syndrome (DS), affecting immune and neurological
function by ill-defined mechanisms. Here we report a large metabolomics study of plasma …

Simple Summary Epithelial–mesenchymal transition (EMT) and its reverse process
mesenchymal–epithelial transition (MET) are considered critical events in the cancer …

Breast cancer is one of the genetic diseases causing a high mortality among women around
the world. Despite the availability of advanced diagnostic tools and treatment strategies, the …

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, with
clinical features of high metastatic potential, susceptibility to relapse, and poor prognosis …